Form 4 Tracker
Opus Genetics, Inc.
IRD

27 insider filings · Latest: May 18, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 18, 2026May 20 11:29 PMFoundation Fighting Blindness Retinal Degeneration FundDirector, Other
Sale
1,700,000$4.35$7.4M3,792,171(D)

View →

Apr 23, 2026Apr 27 8:28 PMBenjamin R YerxaDirector, President
Sale
7,470$5.24$39.1K711,535(D)

View →

Apr 23, 2026Apr 27 8:28 PMJoseph K SchachleChief Operating Officer
Sale
4,697$5.22$24.5K296,084(D)

View →

Apr 23, 2026Apr 27 8:27 PMRabourn Amy ZarembaHead of Fin. Quality Assurance
Sale
1,641$5.20$8.5K188,671(D)

View →

Apr 23, 2026Apr 27 8:27 PMGeorge MagrathDirector, Chief Executive Officer
Sale
9,511$5.22$49.6K1,741,344(D)

View →

Apr 23, 2026Apr 27 8:26 PMAshwath JayagopalChief Scientific & Dev. Ofc.
Sale
7,542$5.19$39.2K509,233(D)

View →

Apr 23, 2026Apr 27 8:26 PMRobert E. GagnonChief Financial Officer
Sale
7,842$5.18$40.7K592,158(D)

View →

Apr 23, 2026Apr 23 10:11 PMSCHACHLE JOSEPH K
Proposed Sale
4,697$5.22$24.5K

View →

Apr 23, 2026Apr 23 9:55 PMYERXA BENJAMIN R
Proposed Sale
7,470$5.24$39.1K

View →

Apr 23, 2026Apr 23 8:36 PMMagrath George
Proposed Sale
9,511$13.39$127.3K

View →

Apr 23, 2026Apr 23 8:08 PMGagnon Robert E.
Proposed Sale
7,842$5.18$40.7K

View →

Apr 23, 2026Apr 23 7:49 PMJayagopal Ashwath
Proposed Sale
7,542$5.19$39.2K

View →

Mar 16, 2026Mar 18 8:12 PMJoseph K SchachleChief Operating Officer
Sale
3,719$5.25$19.5K300,781(D)

View →

Mar 16, 2026Mar 18 8:11 PMRabourn Amy ZarembaHead of Fin. Quality Assurance
Sale
2,816$5.25$14.8K190,312(D)

View →

Mar 16, 2026Mar 18 8:10 PMGeorge MagrathDirector, Chief Executive Officer
Sale
24,438$5.21$127.3K1,750,855(D)

View →

Mar 16, 2026Mar 18 8:09 PMAshwath JayagopalChief Scientific & Dev. Ofc.
Sale
3,719$5.12$19.0K516,775(D)

View →

Mar 16, 2026Mar 16 8:54 PMMagrath George
Proposed Sale
24,438$5.21$127.3K

View →

Dec 29, 2025Dec 31 9:33 PMCam GallagherDirector
Purchase
164,000$1.97$323.7K83,000(I)

View →

Stock Options & Derivatives

No transactions found.